Genome-wide DNA methylation at birth in relation to in utero arsenic exposure and the associated health in later life
- PMID: 28558807
- PMCID: PMC5450181
- DOI: 10.1186/s12940-017-0262-0
Genome-wide DNA methylation at birth in relation to in utero arsenic exposure and the associated health in later life
Abstract
Background: In utero arsenic exposure may alter fetal developmental programming by altering DNA methylation, which may result in a higher risk of disease in later life. We evaluated the association between in utero arsenic exposure and DNA methylation (DNAm) in cord blood and its influence in later life.
Methods: Genome-wide DNA methylation in cord blood from 64 subjects in the Taiwanese maternal infant and birth cohort was analyzed. Robust regressions were applied to assess the association of DNA methylation with in utero arsenic exposure. Multiple testing was adjusted by controlling false discovery rate (FDR) of 0.05. The DAVID bioinformatics tool was implemented for functional annotation analyses on the detected CpGs. The identified CpGs were further tested in an independent cohort. For the CpGs replicated in the independent cohort, linear mixed models were applied to assess the association of DNA methylation with low-density lipoprotein (LDL) at different ages (2, 5, 8, 11 and 14 years).
Results: In total, 579 out of 385,183 CpGs were identified after adjusting for multiple testing (FDR = 0.05), of which ~60% were positively associated with arsenic exposure. Functional annotation analysis on these CpGs detected 17 KEGG pathways (FDR = 0.05) including pathways for cardiovascular diseases (CVD) and diabetes mellitus. In the independent cohort, about 46% (252 out of 553 CpGs) of the identified CpGs showed associations consistent with those in the study cohort. In total, 11 CpGs replicated in the independent cohort were in the pathways related to CVD and diabetes mellitus. Via longitudinal analyses, we found at 5 out of the 11 CpGs methylation was associated with LDL over time and interactions between DNA methylation and time were observed at 4 of the 5 CpGs, cg25189764 (coeff = 0.157, p-value = 0.047), cg04986899 (coeff. For interaction [coeff.int] = 0.030, p-value = 0.024), cg04903360 (coeff.int = 0.026, p-value = 0.032), cg08198265 (coeff.int = -0.063, p-value = 0.0021), cg10473311 (coeff.int = -0.021, p-value = 0.027).
Conclusion: In utero arsenic exposure was associated with cord blood DNA methylation at various CpGs. The identified CpGs may help determine pathological epigenetic mechanisms linked to in utero arsenic exposure. Five CpGs (cg25189764, cg04986899, cg04903360, cg08198265 and cg10473311) may serve as epigenetic markers for changes in LDL later in life.
Keywords: Arsenic; CpG; DAVID; DNA methylation; Genome-wide; KEGG pathway; Ldl.
Figures
Similar articles
-
Exposure to Low Levels of Lead in Utero and Umbilical Cord Blood DNA Methylation in Project Viva: An Epigenome-Wide Association Study.Environ Health Perspect. 2017 Aug 25;125(8):087019. doi: 10.1289/EHP1246. Environ Health Perspect. 2017. PMID: 28858830 Free PMC article.
-
Differential DNA methylation in umbilical cord blood of infants exposed to low levels of arsenic in utero.Environ Health Perspect. 2013 Aug;121(8):971-7. doi: 10.1289/ehp.1205925. Epub 2013 Jun 11. Environ Health Perspect. 2013. PMID: 23757598 Free PMC article.
-
In utero arsenic exposure and epigenome-wide associations in placenta, umbilical artery, and human umbilical vein endothelial cells.Epigenetics. 2015;10(11):1054-63. doi: 10.1080/15592294.2015.1105424. Epigenetics. 2015. PMID: 26646901 Free PMC article.
-
Arsenic Exposure and Epigenetic Alterations: Recent Findings Based on the Illumina 450K DNA Methylation Array.Curr Environ Health Rep. 2015 Jun;2(2):137-44. doi: 10.1007/s40572-015-0052-1. Curr Environ Health Rep. 2015. PMID: 26231363 Free PMC article. Review.
-
What Happens In Utero Does Not Stay In Utero: a Review of Evidence for Prenatal Epigenetic Programming by Per- and Polyfluoroalkyl Substances (PFAS) in Infants, Children, and Adolescents.Curr Environ Health Rep. 2023 Mar;10(1):35-44. doi: 10.1007/s40572-022-00387-z. Epub 2022 Nov 22. Curr Environ Health Rep. 2023. PMID: 36414885 Review.
Cited by
-
Update of the risk assessment of inorganic arsenic in food.EFSA J. 2024 Jan 18;22(1):e8488. doi: 10.2903/j.efsa.2024.8488. eCollection 2024 Jan. EFSA J. 2024. PMID: 38239496 Free PMC article.
-
Linking Prenatal Environmental Exposures to Lifetime Health with Epigenome-Wide Association Studies: State-of-the-Science Review and Future Recommendations.Environ Health Perspect. 2023 Dec;131(12):126001. doi: 10.1289/EHP12956. Epub 2023 Dec 4. Environ Health Perspect. 2023. PMID: 38048101 Free PMC article. Review.
-
Arsenic and Diabetes Mellitus: A Putative Role for the Immune System.All Life. 2023;16(1):2167869. doi: 10.1080/26895293.2023.2167869. Epub 2023 Feb 1. All Life. 2023. PMID: 37152101 Free PMC article.
-
Transcriptomic Profiling of Rectus Abdominis Muscle in Women with Gestational Diabetes-Induced Myopathy: Characterization of Pathophysiology and Potential Muscle Biomarkers of Pregnancy-Specific Urinary Incontinence.Int J Mol Sci. 2022 Oct 25;23(21):12864. doi: 10.3390/ijms232112864. Int J Mol Sci. 2022. PMID: 36361671 Free PMC article.
-
Prenatal Exposure to Potentially Toxic Metals and Their Effects on Genetic Material in Offspring: a Systematic Review.Biol Trace Elem Res. 2023 May;201(5):2125-2150. doi: 10.1007/s12011-022-03323-2. Epub 2022 Jun 17. Biol Trace Elem Res. 2023. PMID: 35713810 Review.
References
-
- Rosenberg HG. Systemic arterial disease and chronic arsenicism in infants. Arch Pathol. 1974;97(6):360–365. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical